Results 41 to 50 of about 762 (114)
The safe administration of the blood products in transfusion medicine requires precautionary measures i.e. blood typing and crossmatching between donor and recipient. Regarding this, teaching staff of the Department of Physiology and Radiobiology and Clinic for Internal Diseases of the Faculty of Veterinary Medicine, University of Zagreb decided that ...
Žura Žaja, Ivona +6 more
openaire +1 more source
Red cell alloimmunization in multitransfused hepatobiliary patients at hospital Selayang
BACKGROUND: Transfusion support is vital for the management of patients with hepatobiliary disease. Repeated blood transfusions increase the risk of alloimmunization, i.e., the development of alloantibodies, which might lead to difficulties in blood ...
Prasanthini Nahendran +5 more
doaj +1 more source
Abstract This practical guidance was developed by the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation to support antenatal diagnosis and clinical management in pregnancies at risk for placenta accreta spectrum (PAS).
Andrea Dall'Asta +11 more
wiley +1 more source
Variability of blood parameters across ABO and Rh blood groups: Insights from a master health check-up data of adult population [PDF]
Background: The ABO and Rh blood group systems have been associated with variations in disease susceptibility. This study aimed to assess the variability in blood parameters, including red cell parameters and metabolic parameters (Renal function, hepatic
Joseph KI +4 more
doaj
ABSTRACT Whether erythrocyte transfusion (ET) after kidney transplantation triggers formation of de novo donor‐specific HLA‐antibodies (HLA‐DSA) and rejection remains debated. If this were true, ET should broaden HLA sensitisation, reflected by increased calculated panel reactive antibodies (cPRA) and de novo HLA‐antibody specificities beyond HLA‐DSA ...
Stella L. Gerber +8 more
wiley +1 more source
Abstract Background Human monoclonal (MoAb) anti‐CD38 antibodies, such as daratumumab, are used to treat diseases such as multiple myeloma. Because red blood cells (RBCs) express CD38, these MoAbs interfere with antibody screening and crossmatching in blood banks.
Ayda Javanbakht +3 more
wiley +1 more source
Abstract Background In patients with variant RhD phenotypes, serologic reactions for partial RHD genotypes are indistinguishable from other variants. Study Design and Methods In two US transfusion services, patients were typed for RhD by automated microplate RhD typing (Werfen, Norcross, GA) using two directly agglutinating IgM anti‐D reagents, MS201 ...
Vidyadhari Karne +4 more
wiley +1 more source
When blood is needed but not available: A proposal for measuring patient‐level blood unavailability
Transfusion, EarlyView.
Shreenik Kundu +3 more
wiley +1 more source
– The yearly incidence of anti‐red blood cell antibodies stratified by participant groups and temporal evolution. – Overall significance p = 3.756 × 10−29. ABSTRACT Background Blood transfusion therapies are of vital importance for many patient groups.
Milanka Milosavić +3 more
wiley +1 more source
ABSTRACT Cold agglutinins can be detected in patients with chronic thromboembolic pulmonary hypertension (CTEPH) during pulmonary thromboendarterectomy (PTE) pre‐operative testing. Peri‐operative management of these patients in anticipation of deep hypothermic circulatory arrest can be challenging and has not been standardized. We describe our relevant
Beenish Naqvi +17 more
wiley +1 more source

